AGA Medical Corporation
ProductsProductsPatients & FamiliesAbout AGAClinical Trials
Leading the Way in Structural Heart Disease Treatment and New Solutions for Vascular Conditions

AGA Medical pioneered the repair of congenital and structural heart defects using non-surgical techniques for treating a wide range of these life threatening diseases.

Atrial Septal Defects

Atrial Septal Defects (ASD) are caused by incomplete growth of the tissue wall (septum) that separates the upper chambers of the heart (atria).

Patent Foramen Ovale

A Patent Foramen Ovale (PFO) is a small opening in the wall (septum) between the left atrium and the right atrium.

Ventricular Septal Defects

Ventricular Septal Defects (VSD) are caused by incomplete growth of the tissue wall (septum) that separates the lower chambers of the heart (ventricles).

Vascular Occlusion

Blood vessel occlusion (closure) may be used to reduce or eliminate blood flow to a targeted organ, or to reroute blood flow through other vessels.

Current Clinical Trials

Respect LogoRespect Trial - United States
AMPLATZER® PFO Occluder - Notice of Availability - Caution: Investigational device. Limited by Federal (U.S.) law to investigational use.

PremiumPremium Trial - United States
AMPLATZER® PFO Occluder - Notice of Availability - Caution: Investigational device. Limited by Federal (U.S.) law to investigational use.

Prima LogoPrima Trial - Europe and Canada
AMPLATZER® PFO Occluder - Notice of Availability: Contact AGA Medical for more information on Prima Trial approvals for each country.

AVPII

ADO II

SimSuite Training Program. A certification training program for the AMPLATZER® Septal Occluder.